Lonza | LONN - Ativos





Ativos Alterar Data
Akzo Nobel EUR 16.02B 114M 2026-09
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
BASF EUR 79.94B 3.92B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Beiersdorf EUR 13.32B 560M 2026-06
Covestro EUR 13.88B 408M 2026-06
Demant DKK 40.03B 951M 2026-06
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.45B 155.97M 2026-09
Geberit CHF 3.86B 252.6M 2025-12
Genmab DKK 12.52B 139M 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GN Store Nord DKK 30.31B 762M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Johnson Matthey GBP 5.97B 142M 2026-06
Merck EUR 52.69B 383M 2026-06
Novartis USD 117.15B 4.88B 2026-09
Philips EUR 28.03B 1.33B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Sika AG CHF 15.15B 245M 2025-12
Smith & Nephew USD 11.01B 321M 2026-06
Solvay EUR 6.22B 139M 2026-09
UCB EUR 18.16B 971M 2025-12